Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DUK vs GSK✓SelectedUSD · GSKDUK vs GSK performance historyLatest closeAs of+0.16%11/18
Stock and ETF performance explorer

DUK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,781.4%
GSK return
+1,674.3%
Excess return
+1,107.1%
Maximum drawdown
-71.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-1.3%+1.5%+0.5%
7D+1.9%-3.1%+5.0%+2.6%
30D+10.0%-0.9%+10.9%+10.2%
3M+5.8%-4.2%+9.9%+6.6%
6M+7.7%-1.6%+9.3%+7.8%
YTD+14.8%+2.6%+12.2%+13.4%
1Y+8.7%+6.2%+2.5%+6.5%
3Y+61.3%+55.0%+6.3%+42.6%
5Y+60.1%+42.8%+17.3%+43.0%
10Y+164.4%+102.1%+62.3%+117.8%
All+2,781.4%+1,674.3%+1,107.1%+1,505.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling